je.st
news
Seattle Genetics: 3 Reasons Why I Like This Midcap Biotech
2015-09-30 20:28:30| Biotech - Topix.net
Adcetris is in the midst of three Phase 3 and four Phase 2 trials to test its viability in treating other cancers and lymphoma. In the world of small- and mid-cap biotech companies it's often times a feast or famine proposition.
Tags: this
reasons
seattle
genetics
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||